tirzepatide pen how to use Mounjaro® KwikPen® Where and How to Inject
Description
Patients are encouraged to report any suspected side effects to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
The 60 mg vial option is available for at-home administration
6 In the OASIS 4 trial, adults with overweight or obesity who took the 25 mg tablet lost an average of 13.6% of their body weight over 64 weeks, compared with 2.2% on a placebo
Commonly used for: Skin rejuvenation, wound recovery, hair health, and inflammation control
Psychiatry 28 (1), 217229
However, individual tolerance to appetite suppression can vary based on your circadian rhythm, meal timing, and daily activity level
